| NDC Code | 52427-273-75 |
|---|
| Package Description | 75 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (52427-273-75) |
|---|
| Product NDC | 52427-273 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Naprelan |
|---|
| Non-Proprietary Name | Naproxen Sodium |
|---|
| Dosage Form | TABLET, FILM COATED, EXTENDED RELEASE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20140117 |
|---|
| End Marketing Date | 20270701 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA020353 |
|---|
| Manufacturer | Almatica Pharma LLC |
|---|
| Substance Name | NAPROXEN SODIUM |
|---|
| Strength | 500 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC] |
|---|